Clovis Oncology (CLVS) Posts Q2 Loss of 61c/Share, Narrower than Views
Get Alerts CLVS Hot Sheet
Join SI Premium – FREE
Clovis Oncology (NASDAQ: CLVS) reported Q2 EPS of ($0.61), $0.09 better than the analyst estimate of ($0.70).
For earnings history and earnings-related data on Clovis Oncology (CLVS) click here.
For earnings history and earnings-related data on Clovis Oncology (CLVS) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- BayCom Corp (BCML) Misses Q1 EPS by 4c
- Community West Bancshares (CWBC) Tops Q1 EPS by 7c
- Marten Transport (MRTN) Misses Q1 EPS by 2c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!